TRANSDERMAL OR TRANSMUCOSAL DRUG DELIVERY DEVICE

Patent №

US 6,564,092

Granted

2003-05-13

Filed 2000

Owner

HISAMITSU PHARMACEUTICAL CO., INC.

Lab

AI components

1

hardware

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

09445451

A transdermal or transmucosal drug delivery device excellent in terms of drug permeability and skin irritability and capable of reducing power consumption, is disclosed. An output control circuit (4) of an energization pattern controller (1) supplies a combined energization of pulse depolarized type energization and at least one of direct current type energization and pulse energization between an anode-side device (5) and a cathode-side device (6) of iontophoresis. The details of combination of energization in the output control circuit (4) is determined based on external setting of the energization pattern controller (1) or internal storage information.

AI hardwareA61N 1/0432A61N 1/325A61N 1/0436

AI classification

AI hardware0.98
Natural language0.02
Vision0.02
Speech0.01
Evolutionary computation0.00
Planning0.00
Machine learning0.00
Knowledge representation0.00

Ownership

HISAMITSU PHARMACEUTICAL CO., INC.

assignment · 107060131

Assignors

NAKAMURA, KATSUHIRO, KATAGAI, KAZUYA, INOUE, KAZUTAKA, HIGO, NARUHITO

On an employer assignment, the assignors are typically the inventors.

© 2026 NYSGPT2525 LLC